SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-042366
Filing Date
2023-09-01
Accepted
2023-09-01 16:07:07
Documents
1
Period of Report
2023-08-31

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 7277
  Complete submission text file 0001140361-23-042366.txt   9412
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NIHONBASHI-HONCHO YS BLDG 3F 2-2-2 NIHONBASHI-HONCHO, CHUO-KU TOKYO M0 103-0023
Business Address NIHONBASHI-HONCHO YS BLDG 3F 2-2-2 NIHONBASHI-HONCHO, CHUO-KU TOKYO M0 103-0023 81-3-6214-3600
GNI Group Ltd. (Reporting) CIK: 0001958461 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51173 | Film No.: 231232548

Mailing Address 12/F ELITE CENTRE 22 HUNG TO ROAD KWUN TONG KL K3 0000
Business Address 12/F ELITE CENTRE 22 HUNG TO ROAD KWUN TONG KL K3 0000 81-3-6214-3600
GNI Hong Kong Ltd (Reporting) CIK: 0001958509 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51173 | Film No.: 231232547